{"id":399470,"date":"2025-11-23T16:30:27","date_gmt":"2025-11-23T16:30:27","guid":{"rendered":"https:\/\/www.europesays.com\/us\/399470\/"},"modified":"2025-11-23T16:30:27","modified_gmt":"2025-11-23T16:30:27","slug":"cancer-medicine-prices-reduced-by-upto-40","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/399470\/","title":{"rendered":"Cancer Medicine Prices Reduced by upto 40%"},"content":{"rendered":"<p>COLOMBO (News 1st); The list of 350 medicines with maximum prices stipulated was tabled in Parliament today.<\/p>\n<p>The Chairman of the National Medicines Regulatory Authority, Specialist Dr. Ananda Wijewickrama, stated that accordingly, the prices of many types of medicines have decreased by various percentages, subject to a maximum reduction of 40 percent.<\/p>\n<p>The price of Paclitaxel medicine, administered to cancer patients, has been reduced from Rs. 42,000 to Rs. 26,332.<\/p>\n<p>The price of another medicine given to cancer patients, the Cisatracurium Besilate injection, has been reduced from Rs. 3,157 to Rs. 2,610.<\/p>\n<p>The Adalimumab injection, has been reduced from Rs. 74,500 to Rs. 40,717.<\/p>\n<p>The price of the blood pressure medicine Losartan Potassium has been reduced from Rs. 11 to Rs. 8.<\/p>\n<p>The National Medicines Regulatory Authority stated that the price of Mebendazole , used for parasitic worm infections, has been reduced from Rs. 83 to Rs. 50.<\/p>\n","protected":false},"excerpt":{"rendered":"COLOMBO (News 1st); The list of 350 medicines with maximum prices stipulated was tabled in Parliament today. The&hellip;\n","protected":false},"author":3,"featured_media":399471,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[34],"tags":[189345,112656,5347,235,1805,210,1412,1060,1184,122,5824,2853,13331,6769,189347,189346,67,132,189348,68],"class_list":["post-399470","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-189345","tag-112656","tag-by","tag-cancer","tag-control","tag-health","tag-in","tag-medication","tag-medicine","tag-medicines","tag-on","tag-parliament","tag-price","tag-prices","tag-reduced","tag-tabled","tag-united-states","tag-unitedstates","tag-upto","tag-us"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/399470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=399470"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/399470\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/399471"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=399470"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=399470"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=399470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}